Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

REVEALED: Invo bioscience s return on capital employed overview | Rare Historical Photos

INVO Bioscience (NASDAQ:INVO) brought in sales totaling $162.60 thousand during Q1 according to data provided by Benzinga Pro. However, earnings decreased 2959.58%, resulting in a loss of $2.77 million. In Q4, INVO Bioscience earned $97.02 thousand, and total sales reached $3.05 million.

What Is ROCE?

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.